NAD+ Injections vs. IV Drips vs. Supplements: What Actually Raises Your NAD+
Three ways to take NAD+, three very different products. A peptide chemist compares what each route delivers, what the human evidence actually shows, and why NAD+ quality starts with a fragile molecule.
Subscribe to free Peptide 101
Enter your email to be alerted when new articles are posted. It’s free, and no more than a few emails a month.
The short version
- Oral precursors (NR and NMN) have the most human data showing they raise blood NAD+.
- IV drips and injections deliver NAD+ itself and skip the gut, but published human data on direct NAD+ is still thin.
- No route has been proven to slow aging or treat disease.
- NAD+ is chemically fragile, so who makes it and how it’s stored matter as much as the route.
What NAD+ is, and why levels matter
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell. It carries electrons in the reactions that turn food into ATP, the cell’s energy currency. Enzymes involved in DNA repair and cell signaling, including the sirtuins and PARPs, also use it up as they work.
The body constantly rebuilds NAD+ from forms of vitamin B3. Studies show NAD+ falls with age in several tissues, which is why it draws interest for healthy aging. Whether raising it improves health in people is still being studied.1
Option 1: Oral supplements (NAD+, NR, NMN)
Oral precursors have the strongest human evidence for raising blood NAD+. Swallowed NAD+ itself is largely broken down in the gut before it reaches the blood, which is why most oral products use precursors instead.
- Nicotinamide riboside (NR). In a randomized crossover trial of 30 healthy middle-aged and older adults, NR was well tolerated and raised NAD+.2 In older adults with mild cognitive impairment, 1 g/day raised blood NAD+ about 2.6-fold.3
- Nicotinamide mononucleotide (NMN). Small trials report raised NAD+ metabolites and some metabolic changes. In September 2025, the FDA reversed course and confirmed NMN may be sold as a dietary supplement.7
Raising the number has not reliably improved outcomes. A 12-week University of Delaware trial found NR raised blood NAD+ in older adults with mild cognitive impairment but did not significantly improve cognition, cardiovascular function or brain blood flow.4
Supplements are not reviewed by the FDA for content or purity before sale, so what is in the capsule depends entirely on the brand.
Option 2: IV NAD+ drips
IV infusion is the most direct way to put NAD+ into the bloodstream, but it is slow and the body clears it fast. The best-known human study gave healthy men 750 mg of NAD+ over a full six hours.5
For at least the first two hours, the infused NAD+ was removed from the blood as fast as it went in. The body broke it down into metabolites, and some passed into the urine. The study tracked what happened to the molecule, not whether anyone felt or functioned better.
In practice, drips mean a clinic visit, several hours in a chair, and a per-session price. Infusing too fast commonly brings flushing, chest tightness, nausea or cramping, which is why clinics run them slowly.
Option 3: Subcutaneous NAD+ injections at home
Subcutaneous injections deliver NAD+ itself, in small doses under the skin, on a schedule set by a clinician. They skip the gut like an IV does, without the clinic chair or the six-hour drip, and absorption is slower and more gradual than an infusion.
The trade-off is evidence. Published human data on subcutaneous NAD+ are limited. A registered randomized study is now comparing 100 mg of NAD+ and NR given by IV push, intramuscular and subcutaneous injection to measure absorption and tolerability.6
The most common side effects are injection-site redness or soreness, flushing and nausea.
Not the same product: much of the NAD+ sold online for self-injection is research-grade powder labeled “not for human use.” It is a different product entirely from a prescribed, pharmacy-compounded, sterile solution. See 503A pharmacy vs. research grade for what that difference means.
Side by side
| Oral NR / NMN | IV NAD+ drip | SubQ NAD+ injection | |
|---|---|---|---|
| What you take | A precursor the body converts to NAD+ | NAD+ itself, into a vein | NAD+ itself, under the skin |
| Human evidence it raises NAD+ | StrongerSeveral randomized trials | LimitedOne small pharmacokinetic study | LimitedTrials under way |
| Proven health outcomes | Not established | Not established | Not established |
| Time and setting | A daily capsule at home | Hours per session in a clinic | A few minutes at home |
| Prescription | No | Yes | Yes |
| Quality oversight | Supplement rules; no pre-sale review | Varies by clinic and its pharmacy | Depends on the compounding pharmacy |
| Common side effects | Mild stomach upset | Flushing, chest tightness, nausea if run fast | Injection-site soreness, flushing |
What the evidence does and doesn’t show
We know NAD+ is essential, that levels fall with age in several tissues, and that oral precursors can raise blood levels. We do not yet know whether raising NAD+ by any route makes people healthier or slows aging.
Be wary of any provider, drip bar or supplement brand that promises energy, anti-aging or disease benefits as fact. Blood NAD+ is also an imperfect stand-in for what is happening inside muscle, brain or liver cells. A good clinician will treat NAD+ as an option to discuss, not a cure.
Know your vial: five questions to ask any NAD+ provider
NAD+ is a chemically fragile molecule, so quality matters more than the route. In water it slowly breaks apart, and heat and the wrong pH speed that up. A vial can carry less NAD+ than its label says if it was made or stored poorly.
Breakdown products don’t show up as missing on a label. Only an assay of the finished solution tells you how much NAD+ is actually there.
- Which pharmacy makes it? You want a named, licensed U.S. 503A pharmacy, not “our lab” or an unnamed supplier.
- Is there a Certificate of Analysis for the finished product? It should report assay (how much NAD+ is actually in the solution), endotoxin and sterility.
- How is it stored and shipped, and what is the beyond-use date? Ask whether it needs refrigeration and how long it stays in specification.
- Is it ready to use, or a powder you mix yourself? Mixing at home adds contamination and dosing risk.
- Is it prescribed? A clinician should review your history and set your dose, not a website dropdown.
For how to read the certificate itself, see What’s actually in your vial.
Considering NAD+? How AJ Peptide does it
AJ Peptide’s NAD+ is a ready-to-use subcutaneous solution, compounded by VialsRx, a licensed U.S. 503A pharmacy, and released with a Certificate of Analysis available on request. A licensed clinician reviews your health history at no charge and decides whether NAD+ is right for you and at what dose.
$115
your first month ($50 off), then $165/month. Applied automatically.
Rx only. Compounded NAD+ is not FDA-approved, and compounded drugs have not been evaluated by the FDA for safety, effectiveness or quality. Individual results vary. You’re only charged for medication if a clinician prescribes it. First-order discount applies to new patients. Medical evaluations and prescriptions are provided by licensed clinicians of Arora Health & Aesthetics, LLC.
Subscribe to free Peptide 101
Be alerted when new articles are posted: plain-English peptide chemistry, testing standards and clinical evidence. No more than a few emails a month.
References
- Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529–547.
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286.
- Orr ME, et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. 2024.
- University of Delaware. UD study finds limited benefits from boosting NAD+ in older adults with mild cognitive impairment. UDaily, July 2026.
- Grant R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019;11:257.
- ClinicalTrials.gov. Absorption and tolerability of injectable administration of Niagen+, as compared to NAD+ (NCT06919328).
- Venable LLP. FDA declares nicotinamide mononucleotide is a dietary supplement. October 2025.
AJ Peptide is LegitScript certified.